Journal
ONCOGENE
Volume 30, Issue 5, Pages 505-520Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.492
Keywords
calorie restriction; carcinogenesis; NRF2; phytochemicals
Funding
- National Institute on Aging, National Institutes of Health
- Junta de Andalucia [CVI 4887, CVI-276]
- NIH [1R01AG028125-01A1]
- Ministry of Health, Spain [PI080500]
Ask authors/readers for more resources
The transcription factor NF-E2-related factor (NRF2) is a key regulator of several enzymatic pathways, including cytoprotective enzymes in highly metabolic organs. In this review, we summarize the ongoing research related to NRF2 activity in cancer development, focusing on in vivo studies using NRF2 knockout (KO) mice, which have helped in defining the crucial role of NRF2 in chemoprevention. The lower cancer protection observed in NRF2 KO mice under calorie restriction (CR) suggests that most of the beneficial effects of CR on the carcinogenesis process are likely mediated by NRF2. We propose that future interventions in cancer treatment would be carried out through the activation of NRF2 in somatic cells, which will lead to a delay or prevention of the onset of some forms of human cancers, and subsequently an extension of health-and lifespan. Oncogene (2011) 30, 505-520; doi: 10.1038/onc.2010.492; published online 8 November 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available